What Happened?
Washington, WA-based Cyrano-Therapeutics Appointed Rick Geoffrion as President and Chief Executive Officer
About the Company
The Cyrano team has developed a unique, proprietary intranasal product to restore function in patients with a chronic loss of taste and smell. This is a condition affecting at least 14 million people in the US and a similar number in Europe, having a significant impact on safety, quality of life and well-being.
About the Person
Rick Geoffrion is President and Chief Executive Officer at Cyrano Therapeutics. Previously, Rick held various senior HR leadership roles in the industry.
Info Source
News
Short Profile